231 related articles for article (PubMed ID: 36301470)
1. Nanotechnology-Driven Delivery Systems in Inoculation Therapies.
Pereira GC
Methods Mol Biol; 2023; 2575():39-57. PubMed ID: 36301470
[TBL] [Abstract][Full Text] [Related]
2. Latest Trends in Nucleic Acids' Engineering Techniques Applied to Precision Medicine.
Pereira GC
Methods Mol Biol; 2023; 2575():25-38. PubMed ID: 36301469
[TBL] [Abstract][Full Text] [Related]
3. Cationic polymer based nanocarriers for delivery of therapeutic nucleic acids.
Nimesh S; Gupta N; Chandra R
J Biomed Nanotechnol; 2011 Aug; 7(4):504-20. PubMed ID: 21870455
[TBL] [Abstract][Full Text] [Related]
4. Bioengineered nanotechnology for nucleic acid delivery.
Zhang Y; Luo J; Gui X; Zheng Y; Schaar E; Liu G; Shi J
J Control Release; 2023 Dec; 364():124-141. PubMed ID: 37879440
[TBL] [Abstract][Full Text] [Related]
5. Critical review of nucleic acid nanotechnology to identify gaps and inform a strategy for accelerated clinical translation.
Afonin KA; Dobrovolskaia MA; Ke W; Grodzinski P; Bathe M
Adv Drug Deliv Rev; 2022 Feb; 181():114081. PubMed ID: 34915069
[TBL] [Abstract][Full Text] [Related]
6. Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.
Dobrovolskaia MA; McNeil SE
Expert Opin Drug Deliv; 2015 Jul; 12(7):1163-75. PubMed ID: 25994601
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnology-Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID-19 Vaccines.
Rinoldi C; Zargarian SS; Nakielski P; Li X; Liguori A; Petronella F; Presutti D; Wang Q; Costantini M; De Sio L; Gualandi C; Ding B; Pierini F
Small Methods; 2021 Sep; 5(9):e2100402. PubMed ID: 34514087
[TBL] [Abstract][Full Text] [Related]
8. MATra - Magnet Assisted Transfection: combining nanotechnology and magnetic forces to improve intracellular delivery of nucleic acids.
Bertram J
Curr Pharm Biotechnol; 2006 Aug; 7(4):277-85. PubMed ID: 16918404
[TBL] [Abstract][Full Text] [Related]
9. Green nanotechnology-based drug delivery systems for osteogenic disorders.
Medina-Cruz D; Mostafavi E; Vernet-Crua A; Cheng J; Shah V; Cholula-Diaz JL; Guisbiers G; Tao J; García-Martín JM; Webster TJ
Expert Opin Drug Deliv; 2020 Mar; 17(3):341-356. PubMed ID: 32064959
[No Abstract] [Full Text] [Related]
10. Application of vinyl polymer-based materials as nucleic acids carriers in cancer therapy.
Pereira PA; Serra MES; Serra AC; Coelho JFJ
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Sep; 14(5):e1820. PubMed ID: 35637638
[TBL] [Abstract][Full Text] [Related]
11. Nucleic acid-based drug delivery strategies.
Tan X; Jia F; Wang P; Zhang K
J Control Release; 2020 Jul; 323():240-252. PubMed ID: 32272123
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology approaches in the current therapy of skin cancer.
Borgheti-Cardoso LN; Viegas JSR; Silvestrini AVP; Caron AL; Praça FG; Kravicz M; Bentley MVLB
Adv Drug Deliv Rev; 2020 Jan; 153():109-136. PubMed ID: 32113956
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnology for delivery of peptide nucleic acids (PNAs).
Gupta A; Bahal R; Gupta M; Glazer PM; Saltzman WM
J Control Release; 2016 Oct; 240():302-311. PubMed ID: 26776051
[TBL] [Abstract][Full Text] [Related]
14. Nanosize drug delivery system.
Mukherjee B
Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
[TBL] [Abstract][Full Text] [Related]
15. Insights into nucleic acid-based self-assembling nanocarriers for targeted drug delivery and controlled drug release.
Chen K; Zhang Y; Zhu L; Chu H; Shao X; Asakiya C; Huang K; Xu W
J Control Release; 2022 Jan; 341():869-891. PubMed ID: 34952045
[TBL] [Abstract][Full Text] [Related]
16. Engineering DNA scaffolds for delivery of anticancer therapeutics.
Sun W; Gu Z
Biomater Sci; 2015 Jul; 3(7):1018-24. PubMed ID: 26221936
[TBL] [Abstract][Full Text] [Related]
17. Design, preparation and application of nucleic acid delivery carriers.
Yang J; Liu H; Zhang X
Biotechnol Adv; 2014; 32(4):804-17. PubMed ID: 24239630
[TBL] [Abstract][Full Text] [Related]
18. Nanodelivery systems for nucleic acid therapeutics in drug resistant tumors.
Iyer AK; Duan Z; Amiji MM
Mol Pharm; 2014 Aug; 11(8):2511-26. PubMed ID: 24661041
[TBL] [Abstract][Full Text] [Related]
19. Nasal-nanotechnology: revolution for efficient therapeutics delivery.
Kumar A; Pandey AN; Jain SK
Drug Deliv; 2016; 23(3):681-93. PubMed ID: 24901207
[TBL] [Abstract][Full Text] [Related]
20. Structural DNA nanotechnology for intelligent drug delivery.
Chao J; Liu H; Su S; Wang L; Huang W; Fan C
Small; 2014 Nov; 10(22):4626-35. PubMed ID: 24955859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
